Medical News

RSS
Regular bedtime, adequate sleep lead to positive developmental outcomes in children

Regular bedtime, adequate sleep lead to positive developmental outcomes in children

Endocyte presents interim results from phase II trial of EC145 plus Doxil for platinum-resistant ovarian cancer

Endocyte presents interim results from phase II trial of EC145 plus Doxil for platinum-resistant ovarian cancer

Onyx reports encouraging ORR from ongoing Carfilzomib Phase 2 study for multiple myeloma

Onyx reports encouraging ORR from ongoing Carfilzomib Phase 2 study for multiple myeloma

Phase III trial comparing PHP with melphalan to BAC for hepatic metastases highlighted at ASCO 2010

Phase III trial comparing PHP with melphalan to BAC for hepatic metastases highlighted at ASCO 2010

Poniard reports positive data from Phase 3 SPEAR trial of picoplatin for SCLC

Poniard reports positive data from Phase 3 SPEAR trial of picoplatin for SCLC

NewLink Genetics reports positive data from Phase 2 trial of HyperAcute-Pancreas cancer immunotherapy

NewLink Genetics reports positive data from Phase 2 trial of HyperAcute-Pancreas cancer immunotherapy

Addition of sorafenib to chemotherapy regimen not effective against advanced melanoma: Study

Addition of sorafenib to chemotherapy regimen not effective against advanced melanoma: Study

Bright light therapy has significant effects on sleep disturbances associated with combat-related PTSD

Bright light therapy has significant effects on sleep disturbances associated with combat-related PTSD

OXiGENE presents updated data from ZYBRESTAT Phase 2 study in NSCLC at 2010 ASCO

OXiGENE presents updated data from ZYBRESTAT Phase 2 study in NSCLC at 2010 ASCO

Researcher calls stroke specialists to further knowledge and understanding of stroke

Researcher calls stroke specialists to further knowledge and understanding of stroke

Study identifies potential link between Gilbert's Syndrome, childhood acute lymphoblastic leukemia

Study identifies potential link between Gilbert's Syndrome, childhood acute lymphoblastic leukemia

Celldex reports interim positive results from rindopepimut Phase 2b study for GBM at ASCO

Celldex reports interim positive results from rindopepimut Phase 2b study for GBM at ASCO

CPAP Therapy increases gray-matter volume in obstructive sleep apnea patients

CPAP Therapy increases gray-matter volume in obstructive sleep apnea patients

Grifols to acquire Talecris Biotherapeutics

Grifols to acquire Talecris Biotherapeutics

Sleepwalking, bedwetting persist into adolescence

Sleepwalking, bedwetting persist into adolescence

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

Microplasmin exhibits potential to cure 50% of patients with macular hole

Microplasmin exhibits potential to cure 50% of patients with macular hole

Incyte presents additional results from INCB7839 Phase I/II trial for HER2-positive metastatic breast cancer

Incyte presents additional results from INCB7839 Phase I/II trial for HER2-positive metastatic breast cancer

Phase II study results of pomalidomide, dexamethasone for multiple myeloma presented at ASCO

Phase II study results of pomalidomide, dexamethasone for multiple myeloma presented at ASCO

TABS Group estimates U.S. Vitamin, Minerals and Supplements market at $11B

TABS Group estimates U.S. Vitamin, Minerals and Supplements market at $11B

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.